cbdMD Statistics
Share Statistics
cbdMD has 5.54M shares outstanding. The number of shares has increased by 81.9% in one year.
| Shares Outstanding | 5.54M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 47.18% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 4.60M |
| Failed to Deliver (FTD) Shares | 899 |
| FTD / Avg. Volume | 0.11% |
Short Selling Information
The latest short interest is 193.15K, so 3.49% of the outstanding shares have been sold short.
| Short Interest | 193.15K |
| Short % of Shares Out | 3.49% |
| Short % of Float | 4.2% |
| Short Ratio (days to cover) | 1.14 |
Valuation Ratios
The PE ratio is -0.55 and the forward PE ratio is -0.52.
| PE Ratio | -0.55 |
| Forward PE | -0.52 |
| PS Ratio | 0.1 |
| Forward PS | null |
| PB Ratio | 0 |
| P/FCF Ratio | -3.15 |
| PEG Ratio | n/a |
Enterprise Valuation
cbdMD Inc. has an Enterprise Value (EV) of 3.97M.
| EV / Earnings | -1.07 |
| EV / Sales | 0.2 |
| EV / EBITDA | -2.65 |
| EV / EBIT | -1.2 |
| EV / FCF | -6.17 |
Financial Position
The company has a current ratio of 0, with a Debt / Equity ratio of 0.65.
| Current Ratio | 0 |
| Quick Ratio | 0 |
| Debt / Equity | 0.65 |
| Total Debt / Capitalization | 39.28 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0% and return on capital (ROIC) is -0.1%.
| Return on Equity (ROE) | 0% |
| Return on Assets (ROA) | -0.35% |
| Return on Capital (ROIC) | -0.1% |
| Revenue Per Employee | 374.66K |
| Profits Per Employee | -71.16K |
| Employee Count | 52 |
| Asset Turnover | 1.84 |
| Inventory Turnover | 3.17 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -30.67% in the last 52 weeks. The beta is 1.99, so cbdMD 's price volatility has been higher than the market average.
| Beta | 1.99 |
| 52-Week Price Change | -30.67% |
| 50-Day Moving Average | 0.45 |
| 200-Day Moving Average | 0.59 |
| Relative Strength Index (RSI) | 56.74 |
| Average Volume (20 Days) | 783.65K |
Income Statement
In the last 12 months, cbdMD had revenue of 19.48M and earned -3.70M in profits. Earnings per share was 1.93.
| Revenue | 19.48M |
| Gross Profit | 12.00M |
| Operating Income | -3.32M |
| Net Income | -3.70M |
| EBITDA | -1.49M |
| EBIT | -3.32M |
| Earnings Per Share (EPS) | 1.93 |
Balance Sheet
The company has 2.45M in cash and 1.27B in debt, giving a net cash position of -1.27B.
| Cash & Cash Equivalents | 2.45M |
| Total Debt | 1.27B |
| Net Cash | -1.27B |
| Retained Earnings | -182.07B |
| Total Assets | 10.58M |
| Working Capital | -2.23M |
Cash Flow
In the last 12 months, operating cash flow was -352.79K and capital expenditures -290.01K, giving a free cash flow of -642.81K.
| Operating Cash Flow | -352.79K |
| Capital Expenditures | -290.01K |
| Free Cash Flow | -642.81K |
| FCF Per Share | -0.15 |
Margins
Gross margin is 61.57%, with operating and profit margins of -17.02% and -18.99%.
| Gross Margin | 61.57% |
| Operating Margin | -17.02% |
| Pretax Margin | -18.99% |
| Profit Margin | -18.99% |
| EBITDA Margin | -7.67% |
| EBIT Margin | -17.02% |
| FCF Margin | -3.3% |
Dividends & Yields
YCBD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 371.15% |
| FCF Yield | -22.5% |
Analyst Forecast
Currently there are no analyst rating for YCBD.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Apr 25, 2023. It was a backward split with a ratio of 1:45.
| Last Split Date | Apr 25, 2023 |
| Split Type | backward |
| Split Ratio | 1:45 |
Scores
| Altman Z-Score | -23.25 |
| Piotroski F-Score | 2 |